Sarcopenia: a major modifiable cause of frailty in the elderly.
about
Age effect on myocellular remodeling: response to exercise and nutrition in humansBasal muscle amino acid kinetics and protein synthesis in healthy young and older menA comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patientsAn overview of osteoporosis and frailty in the elderly.Television viewing time as a risk factor for frailty and functional limitations in older adults: results from 2 European prospective cohorts.Age-related alterations in oxidatively damaged proteins of mouse skeletal muscle mitochondrial electron transport chain complexes.p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice.Age-associated changes in motor unit physiology: observations from the Baltimore Longitudinal Study of Aging.Frailty, serum androgens, and the CAG repeat polymorphism: results from the Massachusetts Male Aging Study.Shorter telomeres in peripheral blood mononuclear cells from older persons with sarcopenia: results from an exploratory studyAdvantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update.Prognostic value of physical function tests: hand grip strength and six-minute walking test in elderly hospitalized patients.Quadriceps muscle strength, radiographic knee osteoarthritis and knee pain: the ROAD study.Attenuation of p38α MAPK stress response signaling delays the in vivo aging of skeletal muscle myofibers and progenitor cells.The prevalence and incidence of frailty in Pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II)Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study.Age-dependent uncoupling of mitochondria from Ca2⁺ release units in skeletal muscle.Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults.Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy.Three-dimensional analysis of gait in postmenopausal women with low bone mineral density.The effect of combined resistance exercise training and vitamin D3 supplementation on musculoskeletal health and function in older adults: a systematic review and meta-analysis.Frailty: an emerging concept for general practice.Aging, Obesity, and Inflammatory Age-Related Diseases.Socioeconomic Status, Frailty, and All-Cause Mortality in Korean Older Adults: A 3-Year Population-Based Prospective Study.Prediction of sarcopenia using a combination of multiple serum biomarkers.l-Citrulline Supplementation: Impact on Cardiometabolic Health
P2860
Q27024546-F16DB998-F4FD-44E7-AE9F-36292ADB6177Q28353882-8320453F-7D10-47CD-932B-3F0CF30F921EQ28364947-C19D10E0-BE49-4C4D-920C-0CC0BD15AD0CQ30238771-150E6AEF-C09E-4816-AD58-83137A1359C2Q30401395-215FCB63-0CED-4BD7-B603-E0F354314FD9Q33348887-02FF629E-2CF7-4BA4-B5E8-54BD849D0520Q33806427-BE158205-0B64-467E-BBEE-2D6D92CDCFE4Q33867991-D8ABF431-74D7-41AD-98ED-F08B898D8077Q33984883-D90D10CD-A59C-4AE4-B434-2CB6BFFED464Q34102906-915EA91E-7FD3-4E65-B743-D626BA8C4C6FQ34121836-77A188E8-0DE3-40E9-9B70-D45F3EF4411EQ34755202-BD0F6B15-2FFA-4EB0-93A6-3E056BD6F792Q35810805-37B0F8B5-3321-4A81-AD70-198F684BB47AQ36145408-BFC88E1D-5FE5-4A39-B28A-D671559DB906Q36274525-1CCC1CBF-DEA7-4506-B4E6-9D091C58A748Q36537163-22EAEB16-BFB3-4604-8CC8-624BC9611D9EQ36546356-A66D1EF1-0DF3-4A33-98AA-18425B0451C8Q37257924-D3258446-59B8-4B24-8324-19652A592867Q37486939-1FB3290A-68AB-46B4-9CA4-C7A4DD74D421Q37707746-7B5E1DCF-71BF-4357-8AF8-D5941829D705Q38669251-472AF1D0-514E-4495-9AA0-FE74AEFFE56DQ43141370-EBD69B7D-CD35-4E26-9E44-202E860F05B6Q47139877-72B2E3AB-0003-455D-AA72-E0E174EB921AQ48128962-49FA4336-7B4A-4F33-8E36-EBCB81F9EC21Q55384577-5BF1CD2A-EF26-4A67-970C-175FFDA321F5Q57175390-68A77552-AB74-414E-9130-7DDD5D16DEBF
P2860
Sarcopenia: a major modifiable cause of frailty in the elderly.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Sarcopenia: a major modifiable cause of frailty in the elderly.
@ast
Sarcopenia: a major modifiable cause of frailty in the elderly.
@en
type
label
Sarcopenia: a major modifiable cause of frailty in the elderly.
@ast
Sarcopenia: a major modifiable cause of frailty in the elderly.
@en
prefLabel
Sarcopenia: a major modifiable cause of frailty in the elderly.
@ast
Sarcopenia: a major modifiable cause of frailty in the elderly.
@en
P1476
Sarcopenia: a major modifiable cause of frailty in the elderly.
@en
P2093
Roubenoff R
P304
P577
2000-01-01T00:00:00Z